Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Michel Perreault, Marie-Anne Ferlatte, Élise Lachapelle, Guillaume Tremblay & Diana Milton. (2023) Implementation facilitators and barriers to the expansion of a peer-led overdose prevention program. Drugs: Education, Prevention and Policy 0:0, pages 1-9.
Read now
Read now
Anjni Joiner, Lekshmi Kumar, Brian Barhorst & Sabina Braithwaite. (2021) The Role of Emergency Medical Services in the Opioid Epidemic. Prehospital Emergency Care 25:4, pages 462-464.
Read now
Read now
Akiko Kamimura, Samin Panahi, Naveen Rathi, Shannon Weaver, Mu Pye, Kai Sin & Jeanie Ashby. (2020) Risks of opioid abuse among uninsured primary care patients utilizing a free clinic. Journal of Ethnicity in Substance Abuse 19:1, pages 58-69.
Read now
Read now
Mark J. Elzey, Jeffrey Fudin & Eric S. Edwards. (2017) Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems. Expert Opinion on Drug Delivery 14:9, pages 1045-1058.
Read now
Read now
Articles from other publishers (18)
Matthew R. Filteau, Brandn Green, Frances Kim & Ki-Ai McBride. (2022) ‘It’s the same thing as giving them CPR training’: rural first responders’ perspectives on naloxone. Harm Reduction Journal 19:1.
Crossref
Crossref
Renae Fomiatti, Adrian Farrugia, Suzanne Fraser, Robyn Dwyer, Joanne Neale & John Strang. (2020) Addiction stigma and the production of impediments to take-home naloxone uptake. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 26:2, pages 139-161.
Crossref
Crossref
Jessica M. Potts, Betelihem Getachew, Milkie Vu, Eric Nehl, Katherine A. Yeager, Corinne R. Leach & Carla J Berg. (2020) Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors. Journal of Cancer Education 37:1, pages 91-101.
Crossref
Crossref
R. Lyle Cooper, Janese Thompson, Ryan Edgerton, Julia Watson, Samuel A. MacMaster, Medhat Kalliny, Miranda M. Huffman, Paul Juarez, Patricia Mathews-Juarez, Mohammad Tabatabai & Karan P. Singh. (2020) Modeling dynamics of fatal opioid overdose by state and across time. Preventive Medicine Reports 20, pages 101184.
Crossref
Crossref
Braden Bagley & Candace Forbes Bright. (2020) “Those People Count”: Naloxone Media Coverage in Mississippi. Qualitative Health Research 30:8, pages 1237-1248.
Crossref
Crossref
Nathalie Allibe, Francis Billault, Cécile Moreau, Amandine Marchard, Yvan Gaillard, Guillaume Hoizey, Hélène Eysseric-Guerin & Nathalie Milan. (2019) Ocfentanil in France: Seven case reports (2016–2018). Toxicologie Analytique et Clinique 31:4, pages 317-322.
Crossref
Crossref
Amie Goodin, Amanda Fallin-Bennett, Traci Green & Patricia R. Freeman. (2018) Pharmacists’ role in harm reduction: a survey assessment of Kentucky community pharmacists’ willingness to participate in syringe/needle exchange. Harm Reduction Journal 15:1.
Crossref
Crossref
Sarah J. Nechuta, Benjamin D. Tyndall, Sutapa Mukhopadhyay & Melissa L. McPheeters. (2018) Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data. Drug and Alcohol Dependence 190, pages 62-71.
Crossref
Crossref
Bryce Pardo. (2017) Do more robust prescription drug monitoring programs reduce prescription opioid overdose?. Addiction 112:10, pages 1773-1783.
Crossref
Crossref
Tomás Barry, Jan Klimas, Helen Tobin, Mairead Egan & Gerard Bury. (2017) Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision. British Journal of General Practice 67:657, pages e267-e273.
Crossref
Crossref
Shannon G. Panther, Brenda S. Bray & John R. White. (2017) The implementation of a naloxone rescue program in university students. Journal of the American Pharmacists Association 57:2, pages S107-S112.e2.
Crossref
Crossref
Suzanne Nielsen, Nadia Menon, Sarah Larney, Michael Farrell & Louisa Degenhardt. (2016) Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. Addiction 111:12, pages 2177-2186.
Crossref
Crossref
Desiree Madah-Amiri & Thomas Clausen. (2016) The use of public health infrastructure probably the best strategy for national and large-scale naloxone distribution programmes. Addiction 111:7, pages 1309-1310.
Crossref
Crossref
Taletha Mae Derrington, Judith Bernstein, Candice Belanoff, Howard J. Cabral, Hermik Babakhanlou-Chase, Hafsatou Diop, Stephen R. Evans & Milton Kotelchuck. (2015) Refining Measurement of Substance Use Disorders Among Women of Child-Bearing Age Using Hospital Records: The Development of the Explicit-Mention Substance Abuse Need for Treatment in Women (EMSANT-W) Algorithm. Maternal and Child Health Journal 19:10, pages 2168-2178.
Crossref
Crossref
Richard J. Bodnar. (2014) Endogenous opiates and behavior: 2013. Peptides 62, pages 67-136.
Crossref
Crossref
Christine M. Wilder, Fred Wells Brason, Angela K. Clark, Marc Galanter, Alexander Y. Walley & Erin L. Winstanley. (2014) Development and Implementation of an Opioid Overdose Prevention Program Within a Preexisting Substance Use Disorders Treatment Center. Journal of Addiction Medicine 8:3, pages 164-169.
Crossref
Crossref
Roger Chou, Melissa B. Weimer & Tracy Dana. (2014) Methadone Overdose and Cardiac Arrhythmia Potential: Findings From a Review of the Evidence for an American Pain Society and College on Problems of Drug Dependence Clinical Practice Guideline. The Journal of Pain 15:4, pages 338-365.
Crossref
Crossref
Thomas F. Kresina, Robert Lubran & H. Westley Clark. (2014) Technology-Assisted Addiction Treatment for Key Populations. Psychology 05:09, pages 1044-1054.
Crossref
Crossref